NCT03084094View on ClinicalTrials.gov

Neuromodulation and Its Therapeutic Potentiality in Different Populations

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 17, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Fibromyalgia
Interventions
DEVICE

Transcranial Direct Current Stimulation

Non invasive brain modulation at a 2mA current during 20minutes

Trial Locations (1)

Unknown

Hospital Universitário Onofre Lopes, Natal

All Listed Sponsors
lead

Universidade Federal do Rio Grande do Norte

OTHER

NCT03084094 - Neuromodulation and Its Therapeutic Potentiality in Different Populations | Biotech Hunter | Biotech Hunter